{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:18:44Z","timestamp":1790057924093,"version":"4.0.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.taap.2012.07.002","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T12:49:45Z","timestamp":1342788585000},"page":"303-314","source":"Crossref","is-referenced-by-count":15,"title":["Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal"],"prefix":"10.1016","volume":"263","author":[{"given":"Kirill","family":"Tsirulnikov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Abuladze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatol","family":"Bragin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym","family":"Faull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duilio","family":"Cascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Damoiseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Schibler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pushkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2012.07.002_bb0005","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.freeradbiomed.2008.08.012","article-title":"Oxidative damage in brain from human mutant APP\/PS-1 double knock-in mice as a function of age","volume":"45","author":"Abdul","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2012.07.002_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.taap.2012.07.002_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0098-2997(03)00012-8","article-title":"Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways","volume":"24","author":"Alary","year":"2003","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.taap.2012.07.002_bb0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1054-3589(08)61042-X","article-title":"Aminoacylases","volume":"27","author":"Anders","year":"1994","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.002_bb0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/10408448809037470","article-title":"Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites","volume":"18","author":"Anders","year":"1988","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2012.07.002_bb0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neures.2006.10.011","article-title":"N-acetylcysteine and ebselen but not nifedipine protected cerebellar granule neurons against 4-hydroxynonenal-induced neuronal death","volume":"27","author":"Arakawa","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.taap.2012.07.002_bb0035","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3233\/JAD-2010-091723","article-title":"Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment","volume":"21","author":"Baldeiras","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.taap.2012.07.002_bb0040","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1021\/tx9001429","article-title":"Cysteine conjugate \u03b2-lyase activity of rat erythrocytes and formation of \u03b2-lyase-derived globin monoadducts and cross-links after in vitro exposure of erythrocytes to S-(1,2-dichlorovinyl)-l-cysteine","volume":"22","author":"Barshteyn","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.07.002_bb0045","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.bbalip.2010.02.005","article-title":"Involvements of the lipid peroxidation product, 4HNE, in the pathogenesis and progression of Alzheimer's disease","volume":"1801","author":"Butterfield","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2012.07.002_bb0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1471-4159.1999.0720751.x","article-title":"Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease","volume":"72","author":"Calingasan","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2012.07.002_bb0055","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3233\/JAD-2010-100012","article-title":"Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease","volume":"20","author":"Carlsson","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.taap.2012.07.002_bb0060","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00702-007-0697-5","article-title":"Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease","volume":"114","author":"Chen","year":"2007","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.taap.2012.07.002_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1054-3589(08)61030-3","article-title":"Enzymology of cysteine S-conjugate \u03b2-lyases","volume":"27","author":"Cooper","year":"1994","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.002_bb0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.neuint.2003.12.002","article-title":"The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants","volume":"44","author":"Cooper","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.taap.2012.07.002_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/0471140856.tx0436s44","article-title":"Measurement of cysteine S-conjugate \u03b2-lyase activity","author":"Cooper","year":"2010","journal-title":"Curr. Protoc. Toxicol."},{"key":"10.1016\/j.taap.2012.07.002_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00726-010-0552-0","article-title":"Cysteine S-conjugate \u03b2-lyases: important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agents","volume":"41","author":"Cooper","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.taap.2012.07.002_bb0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/156720509787313970","article-title":"DNA damage and repair in Alzheimer's disease","volume":"6","author":"Coppede","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.taap.2012.07.002_bb0090","first-page":"1","article-title":"NIH State-of-the-Science Conference statement: preventing Alzheimer's disease and cognitive decline","volume":"27","author":"Daviglus","year":"2010","journal-title":"NIH Consens. State Sci. Statements"},{"key":"10.1016\/j.taap.2012.07.002_bb0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics","volume":"3","author":"de la Torre","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.taap.2012.07.002_bb0095","first-page":"114","article-title":"Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: cysteine conjugate \u03b2-lyase pathway","volume":"27","author":"Dekant","year":"1994","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.002_bb0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1474-4422(04)00809-9","article-title":"Metals in our minds: therapeutic implications for neurodegenerative disorders","volume":"3","author":"Doraiswamy","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.taap.2012.07.002_bb0110","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.freeradbiomed.2010.11.026","article-title":"Neuroprotective strategies involving ROS in Alzheimer disease","volume":"51","author":"Dumont","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2012.07.002_bb0115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","article-title":"Use of ibuprofen and risk of Parkinson disease","volume":"76","author":"Gao","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.taap.2012.07.002_bb0120","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1017\/S1462399411001918","article-title":"Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases","volume":"13","author":"Grammas","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.taap.2012.07.002_bb0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-2009-1063","article-title":"Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease","volume":"17","author":"Grossi","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.taap.2012.07.002_bb0130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the etiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.taap.2012.07.002_bb0135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jb\/mvq099","article-title":"Dual role of the carboxyl-terminal region of pig liver l-kynurenine 3-monooxygenase: mitochondrial-targeting signal and enzymatic activity","volume":"148","author":"Hirai","year":"2010","journal-title":"J. Biochem."},{"key":"10.1016\/j.taap.2012.07.002_bb0140","doi-asserted-by":"crossref","first-page":"17962","DOI":"10.1073\/pnas.1006687107","article-title":"Structures of aminoacylase 3 in complex with acetylated substrates","volume":"107","author":"Hsieh","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2012.07.002_bb0145","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/jnr.22422","article-title":"Potential in vivo amelioration by N-acetyl-l-cysteine of oxidative stress in brain in human double mutant APP\/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment","volume":"88","author":"Huang","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.taap.2012.07.002_bb0150","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/bi971958i","article-title":"Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal","volume":"37","author":"Humphries","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.taap.2012.07.002_bb0155","first-page":"1","article-title":"Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?","volume":"2","author":"Imbimbo","year":"2010","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.taap.2012.07.002_bb0160","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/1522-2683(200209)23:17<3041::AID-ELPS3041>3.0.CO;2-Q","article-title":"Enantioselective analysis of ibuprofen in human plasma by anionic cyclodextrin-modified electrokinetic chromatography","volume":"23","author":"Jabor","year":"2002","journal-title":"Electrophoresis"},{"key":"10.1016\/j.taap.2012.07.002_bb0165","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0026-895X(25)09884-0","article-title":"Immunochemical localization of glutamine transaminase K, a rat kidney cysteine conjugate beta-lyase, and the relationship to the segment specificity of cysteine conjugate nephrotoxicity","volume":"34","author":"Jones","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.002_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2011.02.008","article-title":"System biology of Alzheimer's disease: how diverse molecular changes result in memory impairment in AD","author":"Juhasz","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.taap.2012.07.002_bb0175","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.taap.2012.07.002_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s002040050367","article-title":"Intranephron distribution of cysteine S-conjugate beta-lyase activity and its implication for hexachloro-1,3-butadiene-induced nephrotoxicity in rats","volume":"71","author":"Kim","year":"1997","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2012.07.002_bb0185","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0009-2797(91)90068-I","article-title":"Bioactivation of xenobiotics by formation of toxic glutathione conjugates","volume":"77","author":"Koob","year":"1991","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2012.07.002_bb0190","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1515\/znc-1977-5-605","article-title":"Renal aminoacylase, a zinc enzyme","volume":"32C","author":"K\u00f6rdel","year":"1977","journal-title":"Z. Naturforsch."},{"key":"10.1016\/j.taap.2012.07.002_bb0195","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/brain\/awn008","article-title":"Cyclooxygenase-2 inhibition improves amyloid-\u03b2-mediated suppression of memory and synaptic plasticity","volume":"131","author":"Kotilinek","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.taap.2012.07.002_bb0200","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1080\/15287390500360133","article-title":"Metabolism and tissue distribution of orally administered trichloroethylene in male and female rats: identification of glutathione- and cytochrome P450-derived metabolites in liver, kidney, blood and urine","volume":"69","author":"Lash","year":"2006","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.taap.2012.07.002_bb0205","doi-asserted-by":"crossref","first-page":"44496","DOI":"10.1074\/jbc.M304233200","article-title":"Essential roles of zinc ligation and enzyme dimerization for catalysis in the aminoacylase-1\/M20 family","volume":"278","author":"Lindner","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.07.002_bb0210","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.biochi.2007.12.006","article-title":"N-acetylamino acid utilization by kidney aminoacylase-1","volume":"90","author":"Lindner","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.taap.2012.07.002_bb0215","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/ijc.25798","article-title":"Differential aminoacylase expression in neuroblastoma","volume":"129","author":"Long","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2012.07.002_bb0225","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1093\/nar\/gkm821","article-title":"Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease","volume":"35","author":"Lovell","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.taap.2012.07.002_bb0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2007.07.030","article-title":"Oxidatively modified RNA in mild cognitive impairment","volume":"29","author":"Lovell","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.taap.2012.07.002_bb0220","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0197-4580(97)00108-5","article-title":"Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease","volume":"18","author":"Lovell","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.taap.2012.07.002_bb0235","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0197-4580(00)00235-9","article-title":"Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures","volume":"22","author":"Lovell","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.taap.2012.07.002_bb0240","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/rcm.743","article-title":"Characterisation of adducts of the lipid peroxidation product 4-hydroxy-2-nonenal and amyloid beta-peptides by liquid chromatography\/electrospray ionisation mass spectrometry","volume":"16","author":"Magni","year":"2002","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.taap.2012.07.002_bb9000","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1471-4159.1994.62051983.x","article-title":"Glutamine transaminase K and \u03c9-amidase activities in primary cultures of astrocytes and neurons and in embryonic forebrain: marked induction of brain glutamine transaminase K at time of hatching","volume":"62","author":"Makar","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2012.07.002_bb0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejps.2004.10.004","article-title":"Inefficient central nervous system delivery limits the use of ibuprofen in neurodegenerative diseases","volume":"24","author":"Mannila","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.taap.2012.07.002_bb0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1096\/fj.11-0102ufm","article-title":"Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and disregulated amyloid metabolism: implications for early detection and therapy","volume":"25","author":"Marchesi","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2012.07.002_bb0255","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ana.20629","article-title":"Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment","volume":"58","author":"Markesbery","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.taap.2012.07.002_bb0260","doi-asserted-by":"crossref","first-page":"44670","DOI":"10.1074\/jbc.M204379200","article-title":"Overexpression of Alzheimer's disease amyloid-\u03b2 opposes the age-dependent elevations of brain copper and iron","volume":"277","author":"Maynard","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.07.002_bb0265","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00005072-199708000-00004","article-title":"4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease","volume":"56","author":"Montine","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.taap.2012.07.002_bb0270","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00005072-199805000-00005","article-title":"Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype","volume":"57","author":"Montine","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.taap.2012.07.002_bb0275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.taap.2012.07.002_bb0280","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1258\/ebm.2011.010355","article-title":"Vascular and metabolic dysfunction in Alzheimer's disease: a review","volume":"236","author":"Murray","year":"2011","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.taap.2012.07.002_bb0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1124\/dmd.106.012062","article-title":"Specificity of aminoacylase III-mediated deacetylation of mercapturic acids","volume":"35","author":"Newman","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.07.002_bb0290","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.2174\/092986707782794078","article-title":"Oxidative RNA damage and neurodegeneration","volume":"14","author":"Nunomura","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.taap.2012.07.002_bb0295","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1042\/bj20030969","article-title":"Detergents profoundly affect inhibitor potencies against both cyclo-oxygenase isoforms","volume":"377","author":"Ouellet","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2012.07.002_bb0300","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/01902149209020656","article-title":"Cellular localization of flavin-containing monooxygenase in rabbit lung","volume":"18","author":"Overby","year":"1992","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.taap.2012.07.002_bb0305","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/13543784.9.3.607","article-title":"Ebselen: prospective therapy for cerebral ischaemia","volume":"9","author":"Parnham","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.taap.2012.07.002_bb0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0169-328X(93)90072-W","article-title":"Brain uptake of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-l-cysteine. The glutathione and cysteine S-conjugates of the neurotoxin dichloroacetylene","volume":"17","author":"Patel","year":"1993","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.taap.2012.07.002_bb0310","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0090-9556(25)08289-3","article-title":"Glutathione-dependent biosynthesis and bioactivation of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-l-cysteine, the glutathione and cysteine S-conjugates of dichloroacetylene, in rat tissues and subcellular fractions","volume":"22","author":"Patel","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.07.002_bb0320","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.biochi.2005.04.002","article-title":"Catabolism of intracellular N-terminal acetylated proteins: involvement of acylpeptide hydrolase and acylase","volume":"87","author":"Perrier","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.taap.2012.07.002_bb0325","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/taap.2002.9506","article-title":"Carbonyl toxicology and Alzheimer's disease","volume":"184","author":"Picklo","year":"2002","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.002_bb0330","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbalip.2010.01.009","article-title":"The neurobiology of isoprostanes and Alzheimer's disease","volume":"1801","author":"Pratico","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2012.07.002_bb0335","doi-asserted-by":"crossref","first-page":"C848","DOI":"10.1152\/ajpcell.00192.2003","article-title":"Structural characterization, tissue distribution, and functional expression of murine aminoacylase III","volume":"286","author":"Pushkin","year":"2004","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.taap.2012.07.002_bb0340","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1074\/jbc.M608126200","article-title":"Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation","volume":"282","author":"Qin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.07.002_bb0345","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal\u2013protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.taap.2012.07.002_bb0350","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/abbi.1993.1567","article-title":"Kynurenine 3-hydroxylase in brain: species activity differences and effect of gerbil cerebral ischemia","volume":"307","author":"Saito","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.taap.2012.07.002_bb0355","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/500563","article-title":"Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism","volume":"78","author":"Sass","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.taap.2012.07.002_bb0360","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","article-title":"4-hydroxynonenal-derived advanced lipid peroxidation and products are increased in Alzheimer's disease","volume":"68","author":"Sayre","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2012.07.002_bb0365","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00702-007-0789-2","article-title":"In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity","volume":"114","author":"Shamoto-Nagai","year":"2007","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.taap.2012.07.002_bb0370","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jnen\/62.2.146","article-title":"Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum","volume":"62","author":"Sidell","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.taap.2012.07.002_bb0375","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/bi061853s","article-title":"The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation","volume":"46","author":"Siegel","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.taap.2012.07.002_bb0380","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-009-0517-0","article-title":"Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis","volume":"118","author":"Sultana","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.taap.2012.07.002_bb0385","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comp. Chem."},{"key":"10.1016\/j.taap.2012.07.002_bb0390","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbapap.2009.03.022","article-title":"Mouse aminoacylase 3: a metalloenzyme activated by cobalt and nickel","volume":"1794","author":"Tsirulnikov","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2012.07.002_bb0395","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/978-1-4684-5952-4_61","article-title":"Kynurenine 3-monooxygenase activity of rat brain mitochondria determined by high performance liquid chromatography with electrochemical detection","volume":"294","author":"Uemura","year":"1991","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.taap.2012.07.002_bb0400","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1021\/tx990090p","article-title":"Acylase-catalyzed deacetylation of haloalkene-derived mercapturates","volume":"12","author":"Uttamsingh","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.07.002_bb0410","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/tx980018b","article-title":"Acylase I-catalyzed deacetylation of N-acetyl-l-cysteines","volume":"11","author":"Uttamsingh","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.07.002_bb0405","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0090-9556(24)15140-9","article-title":"Immunohistochemical localization of the acylases that catalyze the deacetylation of N-acetyl-l-cysteine and haloalkene-derived mercapturates","volume":"28","author":"Uttamsingh","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2012.07.002_bb0415","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bbrc.2005.10.126","article-title":"Aminoacylase I deficiency: a novel inborn error of metabolism","volume":"338","author":"Van Coster","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2012.07.002_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.06.014","article-title":"Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease","volume":"33","author":"Wilkinson","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.taap.2012.07.002_bb0425","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neurobiolaging.2005.06.004","article-title":"Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease","volume":"27","author":"Williams","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.taap.2012.07.002_bb0430","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/bj2960435","article-title":"A comparison of Zn(II) and Co(II) in the kinetics of inactivation of aminoacylase by 1,10-phenanthroline and reconstitution of the apoenzyme","volume":"296","author":"Wu","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2012.07.002_bb0435","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bcp.2008.05.016","article-title":"Role of mitochondrial dysfunction in cellular responses to S-(1,2-dichlorovinyl)-l-cysteine in primary cultures of human proximal tubular cells","volume":"76","author":"Xu","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2012.07.002_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2010.07.013","article-title":"Neuronal vulnerability of stroke-prone spontaneously hypertensive rats to ischemia and its prevention with antioxidants such as vitamin E","volume":"170","author":"Yamagata","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.taap.2012.07.002_bb0445","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.STR.29.1.12","article-title":"Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group","volume":"29","author":"Yamaguchi","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.taap.2012.07.002_bb0455","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12031-007-9033-7","article-title":"Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation","volume":"34","author":"Yang","year":"2008","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.taap.2012.07.002_bb0450","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12031-009-9297-1","article-title":"Coenzyme Q10 reduces beta-amyloid plaque in an APP\/PS1 transgenic mouse model of Alzheimer's disease","volume":"41","author":"Yang","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.taap.2012.07.002_bb0460","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","article-title":"Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease","volume":"93","author":"Yoritaka","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12002943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12002943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:15:12Z","timestamp":1743812112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X12002943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0041008X12002943"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2012.07.002","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}